Related Funds
Fund Name | Location |
Canoe Financial | Alberta, Calgary, Canada |
Declaration Capital | New York, New York, United States |
Gatebridge Investments | Dallas, Texas, United States |
Insignia Ventures Partners | Central Region, Singapore, Singapore |
JIERLING Business Consulting | - |
LEAD | Linköping, Ostergotlands Lan, Sweden |
Multiple Myeloma Research Foundation | Connecticut, Norwalk, United States |
Seligman Private Equity Select | England, London, United Kingdom |
Source Capital | Beijing, Beijing, China |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Mineralys Therapeutics | $118M | 08 Jun 2022 | Radnor, Pennsylvania, United States | ||
DNA Script | $200M | 04 Jan 2022 | France, Ile-de-France, France | ||
Acrivon Therapeutics | $100M | 11 Nov 2021 | Cambridge, Massachusetts, United States | ||
Ikena Oncology | $120M | 05 Jan 2021 | Boston, Massachusetts, United States | ||
Paige | $45M | 18 Dec 2019 | New York, New York, United States | ||
Claret Medical | $14M | 23 Oct 2017 | Santa Rosa, California, United States | ||
PreemaTEX | 01 Oct 2015 | Great River, New York, United States | |||
KellBenx | $10M | 29 Jul 2013 | Massapequa, New York, United States | ||
Corindus | $12M | 14 Apr 2008 | Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Mineralys Therapeutics | $118M | 08 Jun 2022 | Radnor, Pennsylvania, United States | ||
DNA Script | $200M | 04 Jan 2022 | France, Ile-de-France, France | ||
Acrivon Therapeutics | $100M | 11 Nov 2021 | Cambridge, Massachusetts, United States | ||
Ikena Oncology | $120M | 05 Jan 2021 | Boston, Massachusetts, United States | ||
Paige | $45M | 18 Dec 2019 | New York, New York, United States | ||
Claret Medical | $14M | 23 Oct 2017 | Santa Rosa, California, United States | ||
PreemaTEX | 01 Oct 2015 | Great River, New York, United States | |||
KellBenx | $10M | 29 Jul 2013 | Massapequa, New York, United States | ||
Corindus | $12M | 14 Apr 2008 | Massachusetts, United States |